| NDC Code | 0245-1073-15 |
|---|
| Package Description | 500 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (0245-1073-15) |
|---|
| Product NDC | 0245-1073 |
|---|
| Product Type Name | HUMAN PRESCRIPTION DRUG |
|---|
| Proprietary Name | Qudexy |
|---|
| Proprietary Name Suffix | Xr |
|---|
| Non-Proprietary Name | Topiramate |
|---|
| Dosage Form | CAPSULE, EXTENDED RELEASE |
|---|
| Usage | ORAL |
|---|
| Start Marketing Date | 20140411 |
|---|
| Marketing Category Name | NDA |
|---|
| Application Number | NDA205122 |
|---|
| Manufacturer | Upsher-Smith Laboratories, Inc. |
|---|
| Substance Name | TOPIRAMATE |
|---|
| Strength | 200 |
|---|
| Strength Unit | mg/1 |
|---|
| Pharmacy Classes | Decreased Central Nervous System Disorganized Electrical Activity [PE],Cytochrome P450 3A4 Inducers [MoA],Cytochrome P450 2C19 Inhibitors [MoA] |
|---|